Cytokinetics Book Value per Share Trend from 2010 to 2022
CYTK  Stock  USD 50.68 0.12 0.24% 
Cytokinetics  Book Value per Share 
Check Cytokinetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytokinetics main balance sheet or income statement drivers, such as Gross Profit of 59.3 M, Interest Expense of 17.7 M or Operating Expenses of 277 M, as well as many exotic indicators such as Interest Coverage of 7.48, Long Term Debt to Equity of 0.56 or PPandE Turnover of 1.67. Cytokinetics financial statements analysis is a perfect complement when working with Cytokinetics Valuation or Volatility modules. It can also supplement Cytokinetics' financial leverage analysis and stock options assessment as well as various Cytokinetics Technical models . Continue to the analysis of Cytokinetics Correlation against competitors.
Cytokinetics Quarterly Book Value per Share  1.3 
Cytokinetics Book Value per Share Breakdown
Showing smoothed Book Value per Share of Cytokinetics with missing and latest data points interpolated. Measures the ratio between Shareholders Equity and [SharesWA] as adjusted by [ShareFactor].Cytokinetics' Book Value per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytokinetics' overall financial position and show how it may be relating to other accounts over time.
Book Value per Share  10 Years Trend 

Book Value per Share 
Share
Timeline 
Cytokinetics Book Value per Share Regression Statistics
Arithmetic Mean  2.37  
Coefficient Of Variation  54.40  
Mean Deviation  0.95  
Median  2.36  
Standard Deviation  1.29  
Sample Variance  1.66  
Range  4.27  
RValue  (0.54)  
Mean Square Error  1.29  
RSquared  0.29  
Significance  0.06  
Slope  (0.18)  
Total Sum of Squares  19.89 
Cytokinetics Book Value per Share History
Other Fundumenentals of Cytokinetics
Cytokinetics Book Value per Share component correlations
About Cytokinetics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cytokinetics income statement, its balance sheet, and the statement of cash flows. Cytokinetics investors use historical funamental indicators, such as Cytokinetics's Book Value per Share, to determine how well the company is positioned to perform in the future. Although Cytokinetics investors may use each financial statement separately, they are all related. The changes in Cytokinetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytokinetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytokinetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytokinetics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported  Projected for 2022  
Book Value per Share  3.17  2.59  
Tangible Assets Book Value per Share  10.94  8.75  
Enterprise Value  4 B  4.3 B  
Tangible Asset Value  841.3 M  907.7 M 
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cytokinetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Directory Now
Bond DirectoryFind actively traded corporate debentures issued by US companies 
All Next  Launch Module 
Pair Trading with Cytokinetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytokinetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Cytokinetics
0.62  CVM  CelSci Corp  Fiscal Year End 28th of December 2022  PairCorr  
0.78  BCRX  Biocryst Pharma  Normal Trading  PairCorr 
The ability to find closely correlated positions to Cytokinetics could be a great tool in your taxloss harvesting strategies, allowing investors a quick way to find a similarenough asset to replace Cytokinetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytokinetics  that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytokinetics to buy it.
The correlation of Cytokinetics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between 1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytokinetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytokinetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytokinetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better riskadjusted return on your portfolios.Continue to the analysis of Cytokinetics Correlation against competitors. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for Cytokinetics Stock analysis
When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on meanvariance optimization algorithm  Go  
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges  Go  
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sectorfocused investing themes  Go  
Equity ValuationCheck real value of public entities based on technical and fundamental data  Go  
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios  Go  
RiskReturn AnalysisView associations between returns expected from investment and the risk you assume  Go  
Analyst RecommendationsAnalyst recommendations and target price estimates broken down by several categories  Go  
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios.  Go  
Global CorrelationsFind global opportunities by holding instruments from different markets  Go 
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization 4.8 B  Quarterly Revenue Growth YOY 30.29  Return On Assets 0.17  Return On Equity 3.38 
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.